19-nortestosterone 4-hexoxyphenylpropionate is a synthetic steroid hormone that is a derivative of testosterone. It is not a naturally occurring hormone and has no known physiological role in the body. It is a potent anabolic steroid that is used in research to study the effects of anabolic steroids on the body.
Here's a breakdown of why it's important for research:
**Anabolic Effects:**
* **Muscle Growth and Strength:** 19-nortestosterone 4-hexoxyphenylpropionate promotes muscle growth and increases strength by stimulating protein synthesis and nitrogen retention.
* **Red Blood Cell Production:** It can stimulate the production of red blood cells, which carry oxygen to the muscles. This can improve athletic performance and endurance.
**Research Applications:**
* **Muscle Physiology and Metabolism:** This steroid is used in animal models to study how anabolic steroids affect muscle growth, repair, and metabolism.
* **Bone Metabolism:** It can be used to investigate the effects of anabolic steroids on bone formation and strength.
* **Cardiovascular Effects:** Researchers use this steroid to study the potential cardiovascular risks associated with anabolic steroid use.
* **Hormonal Regulation:** It can be used to study how anabolic steroids influence the hormonal balance in the body.
**Important Considerations:**
* **Ethical Concerns:** Research involving anabolic steroids in humans raises ethical concerns due to their potential for adverse effects. Therefore, research is often conducted in animal models.
* **Safety Concerns:** 19-nortestosterone 4-hexoxyphenylpropionate can cause a range of side effects, including liver damage, cardiovascular problems, and hormonal imbalances. It is crucial to conduct research with appropriate safety protocols and ethical considerations.
**Conclusion:**
19-nortestosterone 4-hexoxyphenylpropionate is a valuable research tool for understanding the effects of anabolic steroids. However, its use in research must be carefully monitored and conducted with ethical and safety considerations in mind.
| ID Source | ID |
|---|---|
| PubMed CID | 92341 |
| SCHEMBL ID | 1587450 |
| MeSH ID | M0105910 |
| Synonym |
|---|
| anadur |
| 52279-57-9 |
| [(8r,9s,10r,13s,14s,17s)-13-methyl-3-oxo-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl] 3-(4-hexoxyphenyl)propanoate |
| 19-nortestosterone 4-hexyloxyphenylpropionate |
| nandrolone p-hexyloxyphenylpropionate |
| 19-nortestosterone 4-hexoxyphenylpropionate |
| unii-602jjc2862 |
| einecs 257-810-4 |
| 3-oxo-4-estren-17beta-yl 3-(4-hexyloxyphenyl)propionat |
| estr-4-en-3-one, 17-(3-(4-(hexyloxy)phenyl)-1-oxopropoxy)-, (17beta)- |
| 17beta-hydroxyestr-4-en-3-one 17-(3-(4-(hexyloxy)phenyl)propionate) |
| 602jjc2862 , |
| nandrolone p-hexyloxyphenylpropionate [mi] |
| estr-4-en-3-one, 17-(3-(4-(hexyloxy)phenyl)-1-oxopropoxy)-, (17.beta.)- |
| 19-nortestosterone 3-(p-hexyloxyphenyl)propionate |
| 17.beta.-hydroxy-19-norandrosten-4-en-3-one p-hexyloxyphenylpropionate |
| nhpp |
| anador |
| nandrolone (p-hexyloxyphenyl)propionate |
| anadurine |
| nortestosterone (p-hexyloxyphenyl)propionate |
| 17.beta.-hydroxyestr-4-en-3-one p-(hexyloxy)hydrocinnamate |
| nandrolone p-hexyloxyphenylpropionate [who-dd] |
| estr-4-en-3-one, 17.beta.-hydroxy-, p-(hexyloxy)hydrocinnamate |
| nandrolone hexylophenylpropionate |
| 17.beta.-hydroxyestr-4-en-3-one p-hexyloxyphenylpropionate |
| SCHEMBL1587450 |
| 17beta-[3-(4-hexyloxyphenyl)-propanoyloxy]estr-4-en-3-one |
| PQKRYXHYWWQULJ-JMKYFRMNSA-N |
| DTXSID20966654 |
| (17beta)-17-[3-[4-(hexyloxy)phenyl]-1-oxopropoxy]estr-4-en-3-one |
| Q27263147 |
| Excerpt | Reference | Relevance |
|---|---|---|
| " The method was used to measure serum concentrations of NT, T and DHT in a pharmacokinetic study and in a clinical trial for male fertility control." | ( Pharmacokinetics of 19-nortestosterone esters in normal men. Belkien, L; Gunnarsson, PO; Hano, R; Nieschlag, E; Schürmeyer, T, 1985) | 0.27 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.70) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 3 (37.50%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (62.50%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||